Agenus raises up to $340M to fund MSS colon cancer Phase 3 trial
Go back to Agenus raises up to $340M to fund MSS colon cancer Phase 3 trial| AGENUS (NASDAQ: AGEN) | Delayed: 6.19 +0.66 (11.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.53 | 52 Week High | $7.49 | |||
| Open | $5.53 | 52 Week Low | $2.61 | |||
| Day High | $6.23 | P/E | N/A | |||
| Day Low | $5.46 | EPS | $-1.10 | |||
| Volume | 2,332,499 | |||||
